Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure

Diabetes Care

Volumn 21, Issue 1, 1998, Pages 104-110

  Crepaldi, Gaetano ^a   Carta, Quirico ^a   Deferrari, Giacomo ^a   Mangili, Ruggero ^a   Navalesi, Renzo ^a   Santeusanio, Fausto ^a   Spalluto, Antonio ^a   Vanasia, Alessandro ^a   Villa, G Marco ^a   Nosadini, Romano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; NIFEDIPINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

EID: 6844249427     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.104     Document Type: Article

References (34)

1. Lewis EJ, Hunsicker LG, Bain R, Rohde RD: The effect of angiotensin-converting inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
2. Melbourne Diabetic Nephropathy Study Group: Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ 302:210-216, 1991
3. Mangili R, Deferrari G, Di Mario U, Giampietro O, Navalesi R, Nosadini R, Rigamonti G, Spezia R, Crepaldi R, the Italian Microalbuminuria Study Group: Arterial hypertension and microalbuminuria in IDDM: The Italian Microalbuminuria Study. Diabetologa 37:1015-1024, 1994
4. Eurodiab IDDM Complications Study Group: Microvascular and acute complications in IDDM patients: the Eurodiab IDDM Complications Study. Diabetologia 37:278-285, 1994
5. Mathiensen ER, Hommel E, Smith U, Parving HH: Efficacy of captopril in normotensive diabetic patients with microalbuminuria - 8 years follow-up (Abstract). Diabetologia 38:A46, 1995
6. Viberti GC, Hill RD, Jarret RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet i:1430-1432, 1982
7. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent diabetic patients. N Engl J Med 311:89-93, 1982
8. Schmitz A, Vaeth M, Mogensen CE: Systolic blood pressures relates to the rate of progression of albuminuria in NIDDM. Diabetologia 37:1251-1258, 1994
9. National Diabetes Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 26:1039-1057, 1979
10. Keen H, Chlouverakis C: An immunoassay method for urinary albumin at low concentrations. Lancet ii:913-914, 1963
11. Mangili R, Deferrari G, Di Mario U, Giampietro O, Nosadini R, Rigamonti G, Crepaldi G: Prevalence of hypertension and microalbuminuria in adult IDDM patients without renal failure in Italy: validation of screening techniques to detect microalbuminuria. Acta Diabetol 29:156-166, 1992
12. 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans. J Am Soc Nephrol 7:118-124, 1996
13. Care RN, Feldbruegger D, Westgard J: Evaluation of the adaptation of the glucose peroxide 3-methyl-2 benzothiazolinone hydrazone-N-N dimethyline procedure to the Technicon "SMA" 12/60 and comparison with other automated methods of glucose. Clin Chem 20:595-602, 1974
14. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
15. 1c. Metabolism 28:777-779, 1979
16. Stein EA: Lipids, lipoproteins, and apolipoproteins. In Textbook of Clinical Chemistry. Tietz NW, Ed. Philadelphia, Saunders, 1992, p. 829-900
17. Lin DY: Goodness of fit analysis for the Cox regression model on a class of parameter estimator. J Am Stat Assoc 86:725-728, 1991
18. Cox DR: The Analysis of Binary Data. London, England, U.K., Methuen, 1970
19. Wei LJ, Lachin JM: Two sample asymptotically distribution free tests for incomplete multivariate observations. J Am Stat Assoc 79:635-661, 1984
20. Lachin JM: Some large sample distribution free estimators and tests for multivariate partially incomplete observations from two populations. Stat Med 11:1151-1170, 1992
21. Viberti GC, Mogensen CE, Groop LC, Pauls JF, the European Microalbuminuria Captopril Study Group: Effect of captopril on progression to clinical proteinuria in patients with IDDM and microalbuminuria. JAMA 271:275-279, 1994
22. The Microalbuminuria Captopril Study Group: Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 39:587-93, 1996
23. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38:384-394, 1990
24. Kasiske BL, Kail R, Ma J, Lia M, Keane W: Effect of antihypertensive therapy on the kidney in patients with diabetes: a metaregression analysis. Ann Intern Med 118:129-138, 1993
25. Weidman P, Bochlen LM, De Courten M: Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis. Nephrol Dial Transplant 10 (Suppl. 9):39-45, 1995
26. Chan J, Cockram C, Nicholls M, Cheung C, Swaminathan R: Comparison of enalapril and nifedipine in treating non-insulin-dependent diabetes associated with hypertension: one-year analysis. BMJ 305: 981-985, 1992
27. Lebovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica D, Broadstone V, Schiwartz S, Mengel M, Segal R, Versaggi JA, Belton K: Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria. Kidney Int 45 (Suppl. 1):S150-S155, 1994
28. Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioli M, Carraro A, Tonolo GC, Fresu P, Cerniogoi AM, Fioretto P, Nosadini R: Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 45:216-222, 1996
29. Bakris G, Copley B, Vicknair N, Sadler R, Leurgans S: Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM-associated nephropathy. Kidney Int 50:1641-1650, 1996
30. Levy J, Gavin JR, Sowers JR: Diabetes mellitus: a disease of abnormal cellular calcium metabolism. Am J Med 96:260-273, 1994
31. Duner E, Di Virgilio F, Trevisan R, Cipollina MR, Crepaldi G, Nosadini R: Intracellular free calcium abnormalities in fibroblasts from NIDDM patients with and without arterial hypertension. Hypertension 29:1007-1013, 1997
32. Solini A, Di Virgilio F, Trevisan M, Maioli M, Crepaldi G, Nosadini R: Altered calcium handling in response to fibroblast growth factor by cultured skin fibroblasts from non-insulin-dependent diabetic patients with hypertension and microalbuminuria. Kidney Int 50:618-626, 1996
33. Bakris G: Calcium abnormalities and the diabetic, hypertensive patient: implications of renal preservation in calcium antagonists. In Clinical Medicine. Epstein M, Ed. Philadelphia, Hanley & Belfus, 1992, p. 367-438
34. Fioretto P, Frigato F, Velussi M, Riva F, Muollo B, Carraro A, Brocco E, Cipollina M, Abaterusso C, Trevisan M, Crepaldi G, Nosadini R: Effects of angiotensin-converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. Am J Hypertens 5:837-846, 1992